1. Home
  2. AMPY vs VYGR Comparison

AMPY vs VYGR Comparison

Compare AMPY & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amplify Energy Corp.

AMPY

Amplify Energy Corp.

N/A

Current Price

$3.79

Market Cap

215.9M

Sector

Energy

ML Signal

N/A

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

N/A

Current Price

$3.05

Market Cap

203.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMPY
VYGR
Founded
2011
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
215.9M
203.6M
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
AMPY
VYGR
Price
$3.79
$3.05
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$16.50
AVG Volume (30 Days)
620.9K
750.5K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
232.26
N/A
EPS
N/A
N/A
Revenue
$208,637,000.00
$10,135,000.00
Revenue This Year
N/A
$34.04
Revenue Next Year
$23.83
$7.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.41
$2.88
52 Week High
$6.79
$5.55

Technical Indicators

Market Signals
Indicator
AMPY
VYGR
Relative Strength Index (RSI) 36.80 36.64
Support Level N/A $2.96
Resistance Level $4.23 $4.33
Average True Range (ATR) 0.15 0.18
MACD 0.02 -0.02
Stochastic Oscillator 19.44 10.71

Price Performance

Historical Comparison
AMPY
VYGR

About AMPY Amplify Energy Corp.

Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The companies oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: